FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA

Contents

Part 1: Performance Plan Summary

Introduction from Dr. Mark B. McClellan, M.D., Ph. D., Commissioner of the FDA
Executive Summary

Part 1 Narratives

• Risk Management
• A Strong FDA
• Counterterrorism
• Adverse Events and Medical Errors
• Consumer Information

Part 2: Performance Plan and Report

Introduction
2.1 Agency-Wide
2.2 Foods
2.3 Human Drugs
2.4 Biologics
2.5 Animal Drugs and Feeds
2.6 Medical Devices and Radiological Health
2.7 National Center for Toxicological Research

Appendices

Appendix A--FDA's Plan is Aligned with HHS Strategic Goals
Appendix B--FDA's Progress Measuring Long Term Outcome Goals
Appendix C--Disposition of FY 2003 Goals
Appendix D--Partnerships and Coordination
Appendix E--Verification and Validation
Appendix F--Glossary of Acronyms

To Introduction

Office of Planning Home Page
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | Privacy | Accessibility

FDA Office of Planning